References
- Brunning R D, Bennett J M, Flandrin G, Matutes E, Head D, Vardiman J W, . Myelodysplastic syndromes. WHO Classification Tumours of Haematolopoietic and Lymphoid Tissues, E S Jaffe, N L Harris, H Stein, J W Vardin, et al. IARC, Ryon 2001; 62–73
- Greenberg P, Cox C, LeBeau M M, Fenaux P, Morel P, Sanz G, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 15: 2079–2088
- Nakanishi H, Yoshioka K, Joyama S, Araki N, Myoui A, Ishiguro S, et al. Interleukin-6/soluble interleukin-6 receptor signaling attenuates proliferation and invasion, and induces morphological changes of a newly established pleomorphic malignant fibrous histiocytoma cell line. Am J Pathol 2004; 165: 471–480
- Watari K, Asano S, Shirafuji N, Kodo H, Ozawa K, Takaku F, et al. Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay. Blood 1989; 73: 117–122
- Demetri G D, Griffin J D. Granulocyte colony-stimulating factor and its receptor [review]. Blood 1991; 78: 2791–2808
- Lord B I, Molineux G, Pojda Z, Souza L M, Mermod J J, Dexter T M. Myeloid cell kinetics in mice treated with recombinant interleukin-3, granulocyte colony-stimulating factor (CSF), or granulocyte-macrophage CSF in vivo. Blood 1991; 77: 2154–2159
- Price T H, Chatta G S, Dale D C. Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans. Blood 1996; 88: 335–340
- Sultana T A, Harada H, Ito K, Tanaka H, Kyo T, Kimura A. Expression and functional analysis of granulocyte colony-stimulating factor receptors on CD34++ cells in patients with myelodysplastic syndrome (MDS) and MDS-acute myeloid leukaemia. Br J Haematol 2003; 121: 63–75
- Paraskevas F. Cell interactions in the immune response. Wintrobe's Clinical Haematology, 10th edn, G L Lee, J Foerster, J Lukens, F Paraskevas, J P Greener, G M Rodgers. Wiliams & Wilkins, Baltimore 1999; 544–614